Chemotherapy-induced Peripheral Neuropathy and Depression in Cancer Patients.
10.5388/aon.2015.15.3.149
- Author:
Kyung Yeon KIM
1
;
Seung Hee LEE
;
Pok Ja OH
Author Information
1. Korea Institude of Radiological & Medical Science, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Peripheral Neuropathies;
Neoplasms;
Depression
- MeSH:
Anxiety;
Cross-Sectional Studies;
Depression*;
Drug Therapy;
Hand;
Humans;
Joints;
Nursing;
Peripheral Nervous System Diseases*;
Prevalence
- From:Asian Oncology Nursing
2015;15(3):149-155
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study was to assess chemotherapy induced peripheral neuropathy (CIPN) and to examine the relationship between CIPN and depression. METHODS: A purposive sample of 105 patients treated with chemotherapy were recruited in the cross-sectional survey design. Data were collected using self-report questionnaires. The instruments used were the Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT) and Hospital Anxiety Depression Scale (HADS). RESULTS: The most frequent suffering symptom of CIPN was 'tingling feeling in the hand and foot'. Of the motor symptoms, 'muscle weakness' was the most frequent symptom and 'muscle or joint aches' was the strongest suffering symptom of CIPN. The mean score for suffering of CIPN was 4.1. The mean score was 1.04 for depression and the prevalence was 48.5%. CIPN was significantly positively correlated with depression (r=.38, p<.001). The result of simple regression analysis revealed that CIPN was predictive of depression (R2=.136, p<.001). CONCLUSION: Based on the findings of this study, nursing intervention programs focusing on CIPN management and alleviating depression are recommended.
